Analysis of the antigenic profile of uveal melanoma lesions with anti-cutaneous melanoma-associated antigen and anti-HLA monoclonal antibodies.
暂无分享,去创建一个
S. Ferrone | P. Natali | R. Nardi | O. Segatto | M. Nicotra | A. Bigotti | A. Delovu
[1] J. Schlom,et al. Molecular Profile, Tissue Distribution and Prognostic Evaluation of a Human Melanoma-Carcinoma Antigen Recognized by the Murine Monoclonal Antibody B1.1 , 1988, The International journal of biological markers.
[2] D. Ruiter,et al. Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma. , 1988, The Journal of investigative dermatology.
[3] S. Ferrone,et al. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon. , 1987, Journal of immunology.
[4] J. Bomanji,et al. Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments. , 1987, The British journal of ophthalmology.
[5] D. Ruiter,et al. Heterogeneous expression of melanoma-associated antigens in uveal melanomas. , 1987, Current eye research.
[6] S. Ferrone,et al. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen. , 1987, Cancer research.
[7] D. Elder,et al. Monoclonal antibody-defined correlations in melanoma between levels of GD2 and GD3 antigens and antibody-mediated cytotoxicity. , 1987, Cancer research.
[8] B. Damato,et al. Monoclonal antibodies to human primary uveal melanomas demonstrate tumor heterogeneity. , 1986, Investigative ophthalmology & visual science.
[9] G. Mariani,et al. Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. , 1986, Cancer research.
[10] R. Schroff,et al. Human melanoma-associated antigens: analysis of antigenic heterogeneity by molecular, serologic and flow-cytometric approaches. , 1986, Molecular immunology.
[11] S. Ferrone,et al. Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. , 1986, Human immunology.
[12] R. Folberg,et al. Tissue distribution and biochemical properties of an ocular melanoma-associated antigen. , 1985, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[13] D. Elder,et al. Proton NMR and fast-atom bombardment mass spectrometry analysis of the melanoma-associated ganglioside 9-O-acetyl-GD3. , 1985, The Journal of biological chemistry.
[14] S. Ferrone,et al. Distribution of a cross-species melanoma-associated antigen in normal and neoplastic human tissues. , 1985, The Journal of investigative dermatology.
[15] M. Melamed,et al. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.
[16] H. Dienes,et al. Immunohistochemical localization of ganglioside GD3 in human malignant melanoma, epithelial tumors, and normal tissues. , 1985, Cancer research.
[17] S. Ferrone,et al. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma. , 1985, Cancer research.
[18] R. Folberg,et al. An antimelanoma monoclonal antibody and the histopathology of uveal melanomas. , 1985, Archives of ophthalmology.
[19] D. Elder,et al. Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[20] M. Taniguchi,et al. Syngeneic monoclonal antibodies against melanoma antigens with species specificity and interspecies cross-reactivity. , 1984, The Journal of investigative dermatology.
[21] E. Bröcker,et al. HLA-DR antigen expression in primary melanomas of the skin. , 1984, The Journal of investigative dermatology.
[22] A. Aguzzi,et al. The impact of monoclonal antibodies on the study of human malignant melanoma , 1983, Journal of cutaneous pathology.
[23] S. Larson,et al. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy. , 1983, The Journal of clinical investigation.
[24] S. Ferrone,et al. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen. , 1983, Cancer research.
[25] S. Ferrone,et al. Antigenic heterogeneity of surgically removed primary and autologous metastatic human melanoma lesions. , 1983, Journal of immunology.
[26] J. Cairncross,et al. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets , 1982, The Journal of experimental medicine.
[27] A. Brickenden,et al. Human melanoma‐specific oncofetal antigen defined by a mouse monoclonal antibody , 1982, International journal of cancer.
[28] P. Wernet,et al. Differential inhibition of HLA-D- or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. , 1982, Journal of immunology.
[29] S. Ferrone,et al. A 94,000-dalton glycoprotein expressed by human melanoma and carcinoma cells. , 1982, Journal of the National Cancer Institute.
[30] S. Ferrone,et al. Tissue distribution, molecular profile, and shedding of a cytoplasmic antigen identified by the monoclonal antibody 465.12S to human melanoma cells. , 1982, Cancer research.
[31] S. Ferrone,et al. Distribution and molecular characterization of a cell‐surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies , 1981, International journal of cancer.
[32] V. Quaranta,et al. Serologic and immunochemical characterization of the specificity of four monoclonal antibodies to distinct antigenic determinants expressed on subpopulations of human Ia-like antigens. , 1981, Journal of immunology.
[33] L. Old,et al. Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[34] W. Bodmer,et al. Characterization of a monoclonal anti‐β2‐microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens , 1979, European journal of immunology.
[35] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[36] L. Svennerholm. CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES * , 1963, Journal of neurochemistry.
[37] J. Brown,et al. Difference in cell binding patterns of two monoclonal antibodies recognizing distinct epitopes on a human melanoma-associated oncofetal antigen. , 1987, Molecular immunology.
[38] S. Ferrone,et al. Immunohistochemical detection of antigen in human primary and metastatic melanomas by the monoclonal antibody 140.240 and its possible prognostic significance , 1987, Cancer.
[39] L. Donoso,et al. Antigenic and cellular heterogeneity of primary uveal malignant melanomas. , 1986, Archives of ophthalmology.
[40] K. Lloyd. Human Tumor Antigens: Detection and Characterization with Monoclonal Antibodies , 1983 .
[41] F. Bach,et al. Detection of a novel human class II HLA antigen , 1983, Nature.
[42] J. Burston. Ackerman's Surgical Pathology , 1982 .
[43] F. Calabi,et al. Analysis of HLA-DR polymorphism by two-dimensional peptide mapping. , 1981, Proceedings of the National Academy of Sciences of the United States of America.